TrialArthritis care & research2015

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial.

Arthur Kavanaugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.